Equity firm Stripes has made an undisclosed strategic investment in the Dallas-based coffee shop chain. With 24 units, the ...
Cabotegravir was already approved for use in England and Wales as part of a combination treatment for people living with HIV.
BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesionsData support further development of BT-001 in solid tumors ...
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug ...
The new approvals bring the number of denosumab biosimilars in the US to eight, but price reductions are not yet substantial.
Rahway, New Jersey Tuesday, October 28, 2025, 12:00 Hrs [IST] ...
Findings presented at IDWeek 2025 underscore the importance of considering serotypes that disproportionately impact adults in the U.S. and show greater resistance to commonly prescribed ...
Patients with untreated advanced melanoma do not appear to gain a survival advantage from the addition of a cancer vaccine to pembrolizumab, suggests a trial.
Kim Seon-a, an analyst at Hana Securities, said, “We confirmed the flawless clinical results of the obesity treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback